Avexxin - fighting inflammation
spacer
spacer
spacer
spacer
spacer
spacer
spacer
spacer
 
 
leftgraphic
Avexxin - fighting inflammation
spacer

News Room

April 2009

Avexxin has been granted a significant financial support by the Norwegian Research Council to expand its activities in chemistry and drug discoveries in new indications in chronic inflammatory diseases.

August 2007

Avexxin has entered into an R&D contract with the University of Bern, Prof. Andrea Huwiler at the Institute of Pharmacology, regarding investigation of Avexxin compounds in glomerulonephritis.

January 2007

Avexxin has expanded its R&D collaboration with Synthetica AS, a highly skilled SME in Oslo within organic chemistry.

December 2006

NFR has granted Avexxin important financial support to expand its activities in chemistry and drug discovery in new indications in chronic inflammatory diseases.

February 2006

NFR has granted Avexxin important financial support in relation to Avexxin’s psoriasis program.

March 2005

Avexxin AS was incorporated as a spin off from Leiv Eirikssen Nyskaping AS on the basis of basic research conducted at the Norwegian University of Science and Technology under the leadership of Prof. Berit Johansen at the Department of Biology.

spacer
 
Avexxin - fighting inflammation
spacer Avexxin AS, Department of Biology, Norwegian University of Science and Technology, N-7491 Trondheim, Norway
Tel +47 73 59 61 07. Avexxin©2005. All rights reserved. Disclaimer.
spacer To top | Log on spacer
Avexxin - fighting inflammation